Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

Vaccination with synthetic peptides representing cytotoxic T lymphocyte (CTL) epitopes can lead to a protective CTL-mediated immunity against tumors or viruses. We now report that vaccination with a CTL epitope derived from the human adenovirus type 5 E1A-region (Ad5E1A234-243), which can serve as a...

Popoln opis

Bibliografske podrobnosti

izdano v:	Proc Natl Acad Sci U S A
Principais autores:	Toes, R E, Offringa, R, Blom, R J, Melief, C J, Kast, W M
Format:	Artigo
Jezik:	Inglês
Izdano:	National Academy of Sciences 1996
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38838/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755566/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7855
Oznake:	Označite Brez oznak, prvi označite!